Zai Lab Net Worth
Zai Lab Net Worth Breakdown | ZLAB |
Zai Lab Net Worth Analysis
Zai Lab's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Zai Lab's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Zai Lab's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Zai Lab's net worth analysis. One common approach is to calculate Zai Lab's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Zai Lab's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Zai Lab's net worth. This approach calculates the present value of Zai Lab's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Zai Lab's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Zai Lab's net worth. This involves comparing Zai Lab's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Zai Lab's net worth relative to its peers.
Enterprise Value |
|
To determine if Zai Lab is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Zai Lab's net worth research are outlined below:
| Zai Lab appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 266.72 M. Net Loss for the year was (334.62 M) with loss before overhead, payroll, taxes, and interest of (145.39 M). | |
| Zai Lab currently holds about 1.26 B in cash with (198.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 13.1. | |
| Latest headline from businesswire.com: Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO |
Zai Lab uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Zai Lab. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Zai Lab's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 27th of February 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Zai Lab's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Zai Lab is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Zai Lab backward and forwards among themselves. Zai Lab's institutional investor refers to the entity that pools money to purchase Zai Lab's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Blackrock Inc | 2024-06-30 | 660.6 K | Fmr Inc | 2024-09-30 | 644.9 K | Superstring Capital Management Lp | 2024-09-30 | 626.9 K | Adar1 Capital Management Llc | 2024-09-30 | 532.5 K | Allianz Asset Management Ag | 2024-06-30 | 521.8 K | Cam Group Holding A/s | 2024-09-30 | 500 K | Connor Clark & Lunn Inv Mgmt Ltd | 2024-06-30 | 478.6 K | M&g Plc | 2024-06-30 | 437.3 K | Candriam Luxembourg S.c.a. | 2024-06-30 | 365 K | Wellington Management Company Llp | 2024-06-30 | 7.1 M | Hhg Plc | 2024-06-30 | 6.5 M |
Follow Zai Lab's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.84 B.Market Cap |
|
Project Zai Lab's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.33) | (0.34) | |
| Return On Capital Employed | (0.44) | (0.46) | |
| Return On Assets | (0.32) | (0.34) | |
| Return On Equity | (0.42) | (0.40) |
When accessing Zai Lab's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Zai Lab's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Zai Lab's profitability and make more informed investment decisions.
Please note, the presentation of Zai Lab's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Zai Lab's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Zai Lab's management manipulating its earnings.
Evaluate Zai Lab's management efficiency
Zai Lab has return on total asset (ROA) of (0.2083) % which means that it has lost $0.2083 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3498) %, meaning that it created substantial loss on money invested by shareholders. Zai Lab's management efficiency ratios could be used to measure how well Zai Lab manages its routine affairs as well as how well it operates its assets and liabilities. As of November 26, 2024, Return On Tangible Assets is expected to decline to -0.34. In addition to that, Return On Capital Employed is expected to decline to -0.46. At present, Zai Lab's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Intangible Assets is expected to grow to about 17.3 M, whereas Total Assets are forecasted to decline to about 754.6 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 8.24 | 5.48 | |
| Tangible Book Value Per Share | 8.07 | 5.42 | |
| Enterprise Value Over EBITDA | 1.42 | 1.49 | |
| Price Book Value Ratio | 0.32 | 0.34 | |
| Enterprise Value Multiple | 1.42 | 1.49 | |
| Price Fair Value | 0.32 | 0.34 | |
| Enterprise Value | -518.9 M | -493 M |
Evaluating the management effectiveness of Zai Lab allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The Zai Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Enterprise Value Revenue 6.2898 | Revenue 355.7 M | Quarterly Revenue Growth 0.477 | Revenue Per Share 3.647 | Return On Equity (0.35) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Zai Lab insiders, such as employees or executives, is commonly permitted as long as it does not rely on Zai Lab's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Zai Lab insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Zai Lab Corporate Filings
| 15th of November 2024 Other Reports | ViewVerify | |
13A | 14th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
8K | 13th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 8th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
Zai Lab Earnings per Share Projection vs Actual
Zai Lab Corporate Management
| Peter Huang | Chief Officer | Profile | |
| Dr MBA | Chief Officer | Profile | |
| Joshua Smiley | Chief Officer | Profile | |
| Frazor III | Chief Sec | Profile | |
| Christine Chiou | Senior Relations | Profile | |
| Harald MD | Autoimmune Neuroscience | Profile |
Already Invested in Zai Lab?
The danger of trading Zai Lab is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Zai Lab is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Zai Lab. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Zai Lab is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Zai Lab offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zai Lab's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zai Lab Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zai Lab Stock: Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zai Lab. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Zai Stock refer to our How to Trade Zai Stock guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zai Lab. If investors know Zai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zai Lab listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.80) | Revenue Per Share 3.647 | Quarterly Revenue Growth 0.477 | Return On Assets (0.21) | Return On Equity (0.35) |
The market value of Zai Lab is measured differently than its book value, which is the value of Zai that is recorded on the company's balance sheet. Investors also form their own opinion of Zai Lab's value that differs from its market value or its book value, called intrinsic value, which is Zai Lab's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zai Lab's market value can be influenced by many factors that don't directly affect Zai Lab's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zai Lab's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zai Lab is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zai Lab's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.